GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now emerging as a prominent focus in therapeutic studies, largely due to its remarkable impact on treating diseases such as adult-onset diabetes and excess body fat. Ongoing trials have demonstrated that beyond glucose control, GLP-1 drugs offer benefits for heart function and possibly